152 related articles for article (PubMed ID: 27101353)
1. Construction high-yield candidate influenza vaccine viruses in Vero cells by reassortment.
Yu W; Yang F; Yang J; Ma L; Cun Y; Song S; Liao G
J Med Virol; 2016 Nov; 88(11):1914-21. PubMed ID: 27101353
[TBL] [Abstract][Full Text] [Related]
2. Reassortment of high-yield influenza viruses in vero cells and safety assessment as candidate vaccine strains.
Zhou J; Yang F; Yang J; Ma L; Cun Y; Song S; Liao G
Hum Vaccin Immunother; 2017 Jan; 13(1):111-116. PubMed ID: 27648636
[TBL] [Abstract][Full Text] [Related]
3. Preparation and evaluation of a novel, live, attenuated influenza H1N1 vaccine strain produced by a modified classical reassortment method.
Long Y; Ma L; Liu Z; Song S; Geng X; Yang F; Guo Q; Li Z; Li W; Liao G
Hum Vaccin Immunother; 2018 Mar; 14(3):615-622. PubMed ID: 29064728
[TBL] [Abstract][Full Text] [Related]
4. A Vero-cell-adapted vaccine donor strain of influenza A virus generated by serial passages.
Hu W; Zhang H; Han Q; Li L; Chen Y; Xia N; Chen Z; Shu Y; Xu K; Sun B
Vaccine; 2015 Jan; 33(2):374-81. PubMed ID: 25448099
[TBL] [Abstract][Full Text] [Related]
5. Human-Origin Influenza A(H3N2) Reassortant Viruses in Swine, Southeast Mexico.
Nelson MI; Souza CK; Trovão NS; Diaz A; Mena I; Rovira A; Vincent AL; Torremorell M; Marthaler D; Culhane MR
Emerg Infect Dis; 2019 Apr; 25(4):691-700. PubMed ID: 30730827
[TBL] [Abstract][Full Text] [Related]
6. High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1.
Zhou F; Zhou J; Ma L; Song S; Zhang X; Li W; Jiang S; Wang Y; Liao G
Biochem Biophys Res Commun; 2012 May; 421(4):850-4. PubMed ID: 22554519
[TBL] [Abstract][Full Text] [Related]
7. Development and identification of a new Vero cell-based live attenuated influenza B vaccine by a modified classical reassortment method.
Yang F; Ma L; Zhou J; Wu Y; Gao J; Song S; Geng X; Guo Q; Li Z; Li W; Liao G; Li Y
Expert Rev Vaccines; 2017 Aug; 16(8):855-863. PubMed ID: 28581345
[TBL] [Abstract][Full Text] [Related]
8. Suitability of PER.C6 cells to generate epidemic and pandemic influenza vaccine strains by reverse genetics.
Koudstaal W; Hartgroves L; Havenga M; Legastelois I; Ophorst C; Sieuwerts M; Zuijdgeest D; Vogels R; Custers J; de Boer-Luijtze E; de Leeuw O; Cornelissen L; Goudsmit J; Barclay W
Vaccine; 2009 Apr; 27(19):2588-93. PubMed ID: 19428865
[TBL] [Abstract][Full Text] [Related]
9. Seasonal H3N2 and 2009 Pandemic H1N1 Influenza A Viruses Reassort Efficiently but Produce Attenuated Progeny.
Phipps KL; Marshall N; Tao H; Danzy S; Onuoha N; Steel J; Lowen AC
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637755
[TBL] [Abstract][Full Text] [Related]
10. Construction and identification of influenza plasmid pool imparting high yields to candidate vaccine viruses in Vero cell at low temperature.
Liu Z; Geng X; Cui Z; Li W; Ou X; Liao G
J Cell Mol Med; 2020 Oct; 24(19):11198-11210. PubMed ID: 32902192
[TBL] [Abstract][Full Text] [Related]
11. Generation and evaluation of the trivalent inactivated reassortant vaccine using human, avian, and swine influenza A viruses.
Du N; Li W; Li Y; Liu S; Sui Y; Qu Z; Wang Y; Du Y; Xu B
Vaccine; 2008 Jun; 26(23):2912-8. PubMed ID: 18448208
[TBL] [Abstract][Full Text] [Related]
12. [Genome composition analysis of the reassortant influenza viruses used in seasonal and pandemic live attenuated influenza vaccine].
Kiseleva IV; Voeten JT; Teley LC; Larionova NV; Dubrovina IA; Berdygulova ZhA; Bazhenova EA; van den Bosch H; Heldens JG; Rudenko LG
Mol Gen Mikrobiol Virusol; 2011; (4):29-36. PubMed ID: 22312898
[TBL] [Abstract][Full Text] [Related]
13. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a high-growth reassortant H1N1 influenza virus vaccine against the classical swine H1N1 subtype influenza virus in mice and pigs.
Wen F; Yu H; Yang FR; Huang M; Yang S; Zhou YJ; Li ZJ; Tong GZ
Arch Virol; 2014 Nov; 159(11):2957-67. PubMed ID: 24957653
[TBL] [Abstract][Full Text] [Related]
15. The inactivated vaccine of reassortant H3N2 canine influenza virus based on internal gene cassette from PR8 is safe and effective.
Liu Y; Fu C; Ye S; Liang Y; Qi Z; Yao C; Wang Z; Wang J; Cai S; Tang S; Chen Y; Li S
Vet Microbiol; 2021 Mar; 254():108997. PubMed ID: 33524810
[TBL] [Abstract][Full Text] [Related]
16. High genetic and antigenic similarity between a swine H3N2 influenza A virus and a prior human influenza vaccine virus: a possible immune pressure-driven cross-species transmission.
Pan C; Wang G; Liao M; Zhang GH; Jiang S
Biochem Biophys Res Commun; 2009 Jul; 385(3):402-7. PubMed ID: 19463787
[TBL] [Abstract][Full Text] [Related]
17. Novel Reassortant Human-Like H3N2 and H3N1 Influenza A Viruses Detected in Pigs Are Virulent and Antigenically Distinct from Swine Viruses Endemic to the United States.
Rajão DS; Gauger PC; Anderson TK; Lewis NS; Abente EJ; Killian ML; Perez DR; Sutton TC; Zhang J; Vincent AL
J Virol; 2015 Nov; 89(22):11213-22. PubMed ID: 26311895
[TBL] [Abstract][Full Text] [Related]
18. Exploring synergies between academia and vaccine manufacturers: a pilot study on how to rapidly produce vaccines to combat emerging pathogens.
Strecker T; Uhlendorff J; Diederich S; Lenz-Bauer C; Trusheim H; Roth B; Kolesnikova L; Aepinus C; Dornow R; Gerlach J; Matrosovich M; Valley U; Eickmann M; Becker S
Clin Chem Lab Med; 2012 May; 50(7):1275-9. PubMed ID: 22850059
[TBL] [Abstract][Full Text] [Related]
19. Preparation of genetically engineered A/H5N1 and A/H7N1 pandemic vaccine viruses by reverse genetics in a mixture of Vero and chicken embryo cells.
Legastelois I; Garcia-Sastre A; Palese P; Tumpey TM; Maines TR; Katz JM; Vogel FR; Moste C
Influenza Other Respir Viruses; 2007 May; 1(3):95-104. PubMed ID: 19453414
[TBL] [Abstract][Full Text] [Related]
20. [Swine influenza virus: evolution mechanism and epidemic characterization--a review].
Qi X; Lu C
Wei Sheng Wu Xue Bao; 2009 Sep; 49(9):1138-45. PubMed ID: 20030049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
